Showing results (181-190 of 254) with videos related to
Sort By:
Pageof 26
Physical Review Letters|April 12, 2006
Stabilization of nuclear isovector valence-shell excitationsG Rainovski, N Pietralla, T Ahn, et al.International Journal of Integrated Care|September 30, 2024
The Rutgers Integrated Care Evaluation (RICE) Research Framework: An Innovative and Rigorous Set of Methods to Evaluate Integrated Care ProgramsJamey J Lister, Holly H Lister, Kristen G Powell, et al.Bone Marrow Transplantation|February 1, 1995
Reversible cyclosporine-induced cortical blindness in allogeneic bone marrow transplant recipientsM Memon, M deMagalhaes-Silverman, E J Bloom, et al.Clinical Nuclear Medicine|September 1, 1987
The utilization of technetium-99m CPI as a myocardial perfusion imaging agent in exercise studiesS T Sia, B L Holman, S Campbell, et al.Leukemia & Lymphoma|July 12, 2003
Localized lymphoid relapse in the pancreas following allogeneic hematopoietic stem cell transplant for chronic myelogenous leukemiaJ M Rossetti, J Lister, R K Shadduck, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1995
Detecting deep venous thrombosis with technetium-99m-labeled synthetic peptide P280P Muto, S Lastoria, P Varrella, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1984
A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)-technetium(I) [Tc-99m TBI]: initial experience in the humanB L Holman, A G Jones, J Lister-James, et al.American Journal of Clinical Oncology|April 1, 1996
High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancerM deMagalhaes-Silverman, W B Rybka, B Lembersky, et al.European Journal of Nuclear Medicine|January 1, 1986
The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99m hexakis (t-butylisonitrile) technetium (I) (TBI): a new myocardial imaging agentS Campbell, B L Holman, J M Kirshenbaum, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Technetium-99m-white blood cell-specific imaging agent developed from platelet factor 4 to detect infectionB R Moyer, S Vallabhajosula, J Lister-James, et al.Pageof 26